Niklas Huntemann

513 total citations
15 papers, 142 citations indexed

About

Niklas Huntemann is a scholar working on Neurology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Niklas Huntemann has authored 15 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Niklas Huntemann's work include Myasthenia Gravis and Thymoma (5 papers), Multiple Sclerosis Research Studies (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Niklas Huntemann is often cited by papers focused on Myasthenia Gravis and Thymoma (5 papers), Multiple Sclerosis Research Studies (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Niklas Huntemann collaborates with scholars based in Germany, United Kingdom and Czechia. Niklas Huntemann's co-authors include Sven G. Meuth, Marc Pawlitzki, Tobias Ruck, Steffen Pfeuffer, Leoni Rolfes, Heinz Wiendl, Lars Masanneck, Christina B. Schroeter, Michael Bernhard and Stefanie Böck and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Niklas Huntemann

15 papers receiving 142 citations

Peers

Niklas Huntemann

PFM

IMMUN

NEURO

Stanislas Demuth France

Erin A. Boese United States

Azam Qureshi United States

Inez Y. Oh United States

Dumitru Fetco Canada

Pingjiang Ge China

Esha Datta United States

Shannon Beres United States

Haley C. Cropper United States

Hao Yiu United States

Stanislas Demuth France

Niklas Huntemann

96 ×2.3

PFM

56 ×2.0

67 ×2.5

IMMUN

65 ×2.6

NEURO

4 ×0.2

Citations per year, relative to Niklas Huntemann Niklas Huntemann (= 1×) peers Stanislas Demuth

Countries citing papers authored by Niklas Huntemann

Since Specialization

Citations

This map shows the geographic impact of Niklas Huntemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Huntemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Huntemann more than expected).

Fields of papers citing papers by Niklas Huntemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niklas Huntemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Huntemann. The network helps show where Niklas Huntemann may publish in the future.

Co-authorship network of co-authors of Niklas Huntemann

This figure shows the co-authorship network connecting the top 25 collaborators of Niklas Huntemann. A scholar is included among the top collaborators of Niklas Huntemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niklas Huntemann. Niklas Huntemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ruck, Tobias, Niklas Huntemann, Stefanie Schreiber, et al.. (2025). CD19xCD3 T cell engager blinatumomab effective in refractory generalized myasthenic syndromes. Molecular Therapy. 33(9). 4135–4142. 2 indexed citations

Masanneck, Lars, Konstantin Fritz Jendretzky, Niklas Huntemann, et al.. (2025). Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy. Annals of Clinical and Translational Neurology. 12(10). 2045–2055. 1 indexed citations

Masanneck, Lars, et al.. (2024). Triage Performance Across Large Language Models, ChatGPT, and Untrained Doctors in Emergency Medicine: Comparative Study. Journal of Medical Internet Research. 26. e53297–e53297. 34 indexed citations

Schroeter, Christina B., Niklas Huntemann, Saskia Räuber, et al.. (2024). Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice. Cells. 13(6). 508–508. 4 indexed citations

Masanneck, Lars, Niklas Huntemann, Christina B. Schroeter, et al.. (2023). Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study. SHILAP Revista de lepidopterología. 5(1). 39–39. 5 indexed citations

Schroeter, Christina B., Christopher Nelke, Marcus Schewe, et al.. (2023). Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation. Biological Chemistry. 404(4). 355–375. 6 indexed citations

Nelke, Christopher, Christina B. Schroeter, Frauke Stascheit, et al.. (2023). Eculizumab treatment alters the proteometabolome beyond the inhibition of complement. JCI Insight. 8(13). 5 indexed citations

Rolfes, Leoni, Steffen Pfeuffer, Niklas Huntemann, et al.. (2022). Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study. Multiple Sclerosis and Related Disorders. 64. 103931–103931. 17 indexed citations

Nelke, Christopher, Marc Pawlitzki, Christina B. Schroeter, et al.. (2022). High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies. Cells. 11(20). 3330–3330. 3 indexed citations

10.

Pankratz, Susann, Niklas Huntemann, Lars Masanneck, et al.. (2021). Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis. International Journal of Molecular Sciences. 22(18). 9915–9915. 6 indexed citations

11.

Huntemann, Niklas, Leoni Rolfes, Marc Pawlitzki, et al.. (2021). Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020. Drugs. 81(9). 1031–1063. 24 indexed citations

12.

Huntemann, Niklas, et al.. (2021). An optimized and validated protocol for inducing chronic experimental autoimmune encephalomyelitis in C57BL/6J mice. Journal of Neuroscience Methods. 367. 109443–109443. 10 indexed citations

13.

Huntemann, Niklas, Stefan Bittner, Stefanie Böck, Sven G. Meuth, & Tobias Ruck. (2021). Mini-Review: Two Brothers in Crime – The Interplay of TRESK and TREK in Human Diseases. Neuroscience Letters. 769. 136376–136376. 5 indexed citations

14.

Schroeter, Christina B., Niklas Huntemann, Stefanie Böck, et al.. (2021). Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells. Frontiers in Immunology. 12. 747143–747143. 7 indexed citations

15.

Rolfes, Leoni, Marc Pawlitzki, Steffen Pfeuffer, et al.. (2020). Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020. BioDrugs. 34(5). 587–610. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact